UPM Opens Solids Formulation R&D Facility

News provided by

Sep 29, 2015, 10:22 ET

BRISTOL, Tenn., Sept. 29, 2015 /PRNewswire/ -- UPM is excited to announce the opening of its newly designed and qualified Solids Formulation R&D Facility. The facility is comprised of 4,000 square ft with capabilities for a wide range of pharmaceutical formulation development, including four processing suites fitted with down flow booths, a wash room, dedicated feasibility materials storage, humidity controlled capsule shell storage, and an in process testing room. The facility contains dedicated R&D equipment that is state of the art and scalable to clinical processing, including wet and dry granulation, particle size reduction, encapsulation, multi-layer tableting, granules, coating, hot melt extrusion and liquid fill into hard shell capsules. Batches can be processed with as little as a few hundred grams of powder allowing clients to evaluate a broad range of processes before selecting one to scale up. Additionally this saves API that is often expensive or in limited supply.

Jim Gregory, UPM's CEO says, "At UPM we have a strong history of formulation development expertise, now combined with state of the art R&D facilities and equipment. We are your partner from concept to commercial on your journey to market."

Logo - http://photos.prnewswire.com/prnh/20150304/179555LOGO

SOURCE UPM Pharmaceuticals